We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $72.6B
1-Year Est. Return 54.88%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
-3.48%
1 Year Est. Return
+54.88%
3 Year Est. Return
+169.34%
5 Year Est. Return
+186.18%
10 Year Est. Return
+887.93%
AUM
$85.2B
AUM Growth
+$4.83B
Cap. Flow
+$8.98B
Cap. Flow %
10.54%
Top 10 Hldgs %
12.02%
Holding
4,686
New
822
Increased
1,556
Reduced
1,625
Closed
650

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$786M
2
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$409M
3
MU icon
Micron Technology
MU
+$379M
4
T icon
AT&T
T
+$372M
5
MDT icon
Medtronic
MDT
+$370M

Sector Composition

Rank Sector Weight
1 Healthcare 18.69%
2 Technology 14.95%
3 Consumer Discretionary 11.34%
4 Consumer Staples 10.7%
5 Communication Services 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARTL icon
3826
Artelo Biosciences
ARTL
$2.64M
$82K ﹤0.01%
676
+273
+68% +$31.4K
RGF
3827
DELISTED
The Real Good Food Company, Inc. Class A Common Stock
RGF
$82K ﹤0.01%
+868
New +$68.4K
MOHO
3828
DELISTED
ECMOHO Limited American Depositary Shares
MOHO
$82K ﹤0.01%
293,407
+60,000
+26% +$17.9K
IMNM icon
3829
Immunome
IMNM
$3.18B
$80K ﹤0.01%
+14,000
New +$105K
OTRK
3830
DELISTED
Ontrak
OTRK
$79K ﹤0.01%
+386
New +$105K
TOMZ icon
3831
TOMI Environmental Solutions
TOMZ
$12.9M
$78K ﹤0.01%
28,667
+11,300
+65% +$36.6K
SCPS
3832
DELISTED
Scopus BioPharma Inc. Common Stock
SCPS
$78K ﹤0.01%
112,523
+91,623
+438% +$88.4K
BMEA icon
3833
Biomea Fusion
BMEA
$92.8M
$77K ﹤0.01%
17,300
+200
+1% +$1.3K
DUO
3834
Fangdd Network Group
DUO
$24.9M
$77K ﹤0.01%
58
-61
-51% -$81K
JG
3835
Aurora Mobile
JG
$30.4M
$77K ﹤0.01%
3,520
+2
+0.1% +$41
LTRN icon
3836
Lantern Pharma
LTRN
$33.9M
$77K ﹤0.01%
+10,700
New +$71.5K
TCON
3837
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$77K ﹤0.01%
1,460
-9,090
-86% -$457K
HTGM
3838
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$77K ﹤0.01%
4,626
+75
+2% +$2.41K
NEW
3839
DELISTED
Puxin Limited American Depositary Shares, each representing twenty Ordinary Shares
NEW
$77K ﹤0.01%
37,140
+9,820
+36% +$22.6K
ECOR icon
3840
electroCore
ECOR
$84.7M
$76K ﹤0.01%
8,675
-7,181
-45% -$65.1K
QXO
3841
QXO Inc
QXO
$16.1B
$76K ﹤0.01%
+2,903
New +$83.7K
EXTN
3842
DELISTED
Exterran Corporation
EXTN
$76K ﹤0.01%
+12,200
New +$65K
DERM icon
3843
Journey Medical
DERM
$177M
$75K ﹤0.01%
+15,600
New +$77.9K
AIXC
3844
AIxCrypto Holdings Inc
AIXC
$15M
$75K ﹤0.01%
+228
New +$89K
ML
3845
DELISTED
MoneyLion Inc.
ML
$74K ﹤0.01%
+987
New +$77K
ELDN icon
3846
Eledon Pharmaceuticals
ELDN
$291M
$73K ﹤0.01%
18,473
+4,800
+35% +$18.6K
AAU
3847
DELISTED
Almaden Minerals Ltd
AAU
$73K ﹤0.01%
203,700
-269,102
-57% -$86.6K
PYPD icon
3848
PolyPid
PYPD
$92.8M
$72K ﹤0.01%
+440
New +$66.7K
TIRX
3849
DELISTED
Tian Ruixiang Holdings
TIRX
$72K ﹤0.01%
556
+172
+45% +$26.6K
CNTB
3850
Connect Biopharma Holdings
CNTB
$147M
$71K ﹤0.01%
23,500
+12,700
+118% +$53.6K

Similar funds

Jim Simons's Q1 2022 Portfolio in Review

As of Q1 2022, Jim Simons held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Jim Simons deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.

  • Jim Simons's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
  • Jim Simons added most to Tesla in Q1 2022, an estimated $759M increase.
  • Jim Simons's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
  • Jim Simons fully exited Microsoft in Q1 2022, selling an estimated $786M.
  • Jim Simons's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
  • Jim Simons opened 822 new positions and closed 650 in Q1 2022.
  • Jim Simons's portfolio value rose 6% quarter-over-quarter to $85.2B.

Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.